참고문헌 (16)

1. Diabetes Care American Diabetes Association. 35 S64 2012 10.2337/dc12-s064 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 35(Supplement 1): S64-S71 (2012) 

   상세보기

2. Centers for Disease ControlPrevention. 2015 Diabetes Report Card 2014 Centers for Disease Control and Prevention. Diabetes Report Card 2014. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services (2015) 

3. Popul. Health Metrics PB James 8 29 2010 10.1186/1478-7954-8-29 James PB, Theodore JT, Edward WG, Lawrence EB, David FW. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul. Health Metrics 8: 29 (2010) 

   상세보기

4. Lancet GT Adam 379 2279 2012 10.1016/S0140-6736(12)60283-9 Adam GT, Christian H, Wolfgang R, Eric JB, Mika K. Prediabetes: A high-risk state for diabetes development. Lancet 379: 2279-2290 (2012) 

   상세보기

5. Diabetes Care MN David 32 193 2009 10.2337/dc08-9025 David MN, Rury RH, John BB, Robert S, Mayer BD, Bernard Z, Ele F. Medical management of hyperglycemia in Type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 32: 193-203 (2009) 

   상세보기

6. Arch. Med. Sci. G Derosa 8 899 2012 10.5114/aoms.2012.31621 Derosa G, Maffioli P. a-Glucosidase inhibitors and their use in clinical practice. Arch. Med. Sci. 8: 899-906 (2012) 

   상세보기

7. Int. J. Food Microbiol. HK No 74 65 2002 10.1016/S0168-1605(01)00717-6 No HK, Park NY, Lee SH, Samuel PM. Antibacterial activity of chitosans and chitosan oligomers with different molecular weights. Int. J. Food Microbiol. 74: 65-72 (2002) 

   상세보기

8. Biol. Pharm. Bull. H Koji 25 188 2002 10.1248/bpb.25.188 Koji H, Mikio I. Action of low molecular weight chitosan in genetically obese diabetic KK-Ay Mice. Biol. Pharm. Bull. 25: 188-192 (2002) 

   상세보기

9. Biol. Pharm. Bull. H-W Lee 26 1100 2003 10.1248/bpb.26.1100 Lee H-W, Park Y-S, Choi J-W, Yi S-Y, Shin W-S. Antidiabetic effects of chitosan oligosaccharides in neonatal streptozotocin-induced noninsulin-dependent diabetes mellitus in rats. Biol. Pharm. Bull. 26: 1100-1103 (2003) 

   상세보기

10. J. Nutr. MG Cynthia 130 2753 2000 10.1093/jn/130.11.2753 Cynthia MG, Jessa M, Robert HJ, John W, Daniel DG. Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J. Nutr. 130: 2753-2759 (2000) 

    상세보기

11. Int. J. Biol. Macromol. C Qin 31 111 2002 10.1016/S0141-8130(02)00064-8 Qin C, Du Y, Xiao L, Li Z, Gao X. Enzymic preparation of water-soluble chitosan and their antitumor activity. Int. J. Biol. Macromol. 31: 111-117 (2002) 

    상세보기

12. Bioorg. Med. Chem. Lett. L Qi 16 4243 2006 10.1016/j.bmcl.2006.05.078 Qi L, Xu Z. In vivo antitumor activity of chitosan nanoparticles. Bioorg. Med. Chem. Lett. 16: 4243-4245 (2006) 

    상세보기

13. Carbohyd. Polym. MT Yen 74 840 2008 10.1016/j.carbpol.2008.05.003 Yen MT, Yang JH, Mau JL. Antioxidant properties of chitosan from crab shells. Carbohyd. Polym. 74: 840-844 (2008) 

    상세보기

14. Eur. Food Res. Technol. S Tao 225 451 2007 10.1007/s00217-006-0439-1 Tao S, Dongxiang Z, Junlin X, Fang M. Preparation of chitosan oligomers and their antioxidant activity. Eur. Food Res. Technol. 225: 451-456 (2007) 

    상세보기

15. Int. J. Mol. Sci. SH Jo 14 14214 2013 10.3390/ijms140714214 Jo SH, Ha KS, Moon KS, Kim JG, Oh CG, Kim YC, Apostolidis E, Kwon YI. Molecular weight dependent glucose lowering effect of low molecular weight chitosan oligosaccharide (GO2KA1) on postprandial blood glucose level in SD rats model. Int. J. Mol. Sci. 14: 14214-14224 (2013) 

    상세보기

16. Food Sci. Biotechnol. SH Jo 23 971 2014 10.1007/s10068-014-0131-3 Jo SH, Ha KS, Lee JW, Kim YC, Apostolidis E, Kwon YI. The reduction effect of low molecular weight chitosan oligosaccharide (GO2KA1) on postprandial blood glucose levels in healthy individuals. Food Sci. Biotechnol. 23: 971-973 (2014) 

    원문보기 상세보기